Indications and complications of transfusions in sickle cell disease.
about
Blood transfusion for preventing primary and secondary stroke in people with sickle cell diseaseMagnetic resonance imaging in pediatric sickle cell anemia.Trends in blood transfusion among hospitalized children with sickle cell disease.Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.Current management of sickle cell anemia.Profound morphological changes in the erythrocytes and fibrin networks of patients with hemochromatosis or with hyperferritinemia, and their normalization by iron chelators and other agents.Clinical pharmacology of deferasirox.Anti-leukemic properties of deferasirox via apoptosis in murine leukemia cell lines.Clinical and haematological risk factors for cerebral macrovasculopathy in a sickle cell disease newborn cohort: a prospective study.Barriers to using molecularly typed minority red blood cell donors in support of chronically transfused adult patients with sickle cell disease.Predictors of Red Cell Alloimmunization in Kurdish Multi Transfused Patients with Hemoglobinopathies in Iraq.Perfluorocarbon emulsion therapy attenuates pneumococcal infection in sickle cell mice.Severe hemolytic transfusion reaction due to anti-D in a D+ patient with sickle cell disease.Hospitalist management of vaso-occlusive pain crisis in patients with sickle cell disease using a pathway of care.Transient Elastography (TE) is a Useful Tool for Assessing the Response of Liver Iron Chelation in Sickle Cell Disease Patients
P2860
Q24202463-45123CD7-E444-439B-A906-F0CCF33731E4Q31116644-A0340FD5-F7F3-4CA4-B0ED-27923800FB73Q33881818-27751F76-1AA7-4B6F-88A3-1B11ADEC0829Q36251052-2B03B273-28C4-4777-AEBD-CF3ABCE76C9CQ37040238-680A91DA-69FD-40FB-A3A0-CD789DA53345Q37458594-6310552F-E12F-4940-A5DE-9B5B4BF0AC97Q38226394-5C516667-789A-4CCF-AAD0-21E46B71451DQ38892236-CDADB3A5-1E62-47E7-9CB2-490641763D76Q40147937-895CA4DE-5FC3-419C-B5C6-66B0A664637CQ41253789-1787A430-09A3-4953-8194-041A423EDFBFQ41434913-34628813-AA4E-4069-9A2B-8DFFE870BF61Q41646032-53607A23-31E3-47BA-A133-8471271D0642Q43153148-62175B18-756C-4A65-850A-9ED6141EE517Q50693697-29AC47E3-CE14-4EB7-97C5-247A6324D02DQ58775572-726BF363-5F26-475D-B2AC-5486AEFC08D8
P2860
Indications and complications of transfusions in sickle cell disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Indications and complications of transfusions in sickle cell disease.
@en
type
label
Indications and complications of transfusions in sickle cell disease.
@en
prefLabel
Indications and complications of transfusions in sickle cell disease.
@en
P2860
P356
P1476
Indications and complications of transfusions in sickle cell disease.
@en
P2093
Alexis A Thompson
Kim Smith-Whitley
P2860
P304
P356
10.1002/PBC.24179
P577
2012-05-04T00:00:00Z